Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$175,100
+$21,700 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $4,533,137 across 42 Biotechnology names. IBRX ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OMER |
Omeros Corp
|
168,750 | $1,604,812 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
56,723 | $847,441 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,127 | $559,814 | |
| 4 | ANAB |
Anaptysbio, Inc
|
5,000 | $337,500 | |
| 5 | GLSI |
Greenwich LifeSciences, Inc.
|
10,740 | $251,960 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
3,991 | $217,669 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,215 | $175,627 | |
| 8 | IBRX |
ImmunityBio, Inc.
This page
|
20,000 | $175,100 |
All Filings in IBRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,100 | 20,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $153,400 | 20,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $39,600 | 20,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,600 | 10,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $26,400 | 10,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||